Phase 2 Dose-finding IMU-838 for Ulcerative Colitis (CALDOSE-1)
A phase 2, multicenter, randomized, double-blind, placebo controlled, dose-finding study to evaluate the efficacy and safety of IMU 838 for induction and maintenance therapy in moderate-to-severe ulcerative colitis CALDOSE-1 A phase 2, multicenter, randomized, double-blind, placebo controlled, dose-finding study to evaluate ...